Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Efficient iron-catalyzed method for fused ring [1,2-a] indoles. Reduces cost, improves scalability for pharmaceutical intermediate manufacturing.
Patent CN105473546A details a safer synthesis route for R-biphenylalaninol. This method offers cost reduction in API intermediate manufacturing and supply chain reliability.
Advanced preparation method for dexrazoxane via optimized alkylation and cyclization. Reduces inorganic salt waste and eliminates column chromatography for cost-effective manufacturing.
Novel patent CN116478026B offers high-yield tropone skeleton synthesis. Reduces costs and simplifies supply chain for pharmaceutical intermediates manufacturing.
Patent CN102249969A discloses a high-regioselective iridium-catalyzed method for phenyl-(3-aryl-2-propenyl) selenides, offering cost reduction in pharmaceutical intermediate manufacturing.
Novel room-temperature asymmetric catalysis for chiral secondary aryl alcohols. Reduces cost by eliminating noble metals. High yield and ee for pharma intermediates.
Patent CN116041207A reveals a novel chiral spiroindane ligand enabling high-selectivity C-H activation. Discover cost-effective synthesis and supply chain advantages.
Patent CN111285775B reveals a high-efficiency iridium catalytic system for chiral amine synthesis, offering significant cost reduction and scalability for agrochemical intermediates.
Patent CN101481363B reveals a novel amidation route for repaglinide intermediates, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN106834372B reveals a novel transaminase method for (S)-2-aminobutanamide. Achieve >99.5% ee and significant cost reduction in API manufacturing with scalable green chemistry.
Novel microchannel nitration process for irinotecan intermediate ensures safety and yield. Supply chain reliability improved via intrinsic safety design and reduced waste discharge for global buyers.
Novel synthesis route for high-purity pharmaceutical intermediate offering safety and scale-up advantages for global supply chains and cost reduction.
Novel Wittig reaction route enhances purity and yield for gefarnate manufacturing, offering significant supply chain stability and cost reduction benefits for global pharmaceutical partners.
Novel 5-step synthesis of ent-chromazonarol from sclarealdehyde. Reduces steps vs prior art. Suitable for industrial scale-up and supply chain stability.
Patent CN101255171A reveals a safer carbapenem intermediate process eliminating toxic organotin. Achieve cost reduction and supply reliability.
Patent CN105399744B reveals optimized Omarigliptin synthesis. High yield and purity benefit supply chain stability and cost reduction significantly.
Novel efficient route for Xiawu Base B via C-H activation. Reduces cost and improves scalability for pharmaceutical manufacturing using accessible raw materials.
Patent CN105884728B details air-oxidized NHC catalysis for high-purity chiral intermediates, offering cost-effective and scalable manufacturing solutions.
Patent CN103012292A reveals a novel 2-step synthesis for dibenzo[b,f][1,2]diazocine, offering >50% yield and eliminating toxic mercury residues for reliable pharmaceutical intermediate supply.
Novel patent CN115504866B offers high-yield 4-methoxy-2-naphthol synthesis. Improves supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.